Bottom line
What does AGNG hold?
AGNG held 84 positions as of May 31, 2026. Its largest holding is Novo Nordisk A/s at 3.80% of the fund, and the top 10 positions add up to 32.1%. By asset type it is 100% stocks.
Updated Jul 29, 2026
AGNG top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Novo Nordisk A/s NOVO NORDISK A/S-B COMMON STOCK |
Stocks | 3.80% | $3.1M |
| 2 | Eli Lilly And Company ELI LILLY & CO COMMON STOCK |
Stocks | 3.58% | $2.9M |
| 3 | Edwards Lifesciences Corporation EDWARDS LIFESCIENCES CORP COMMON STOCK |
Stocks | 3.37% | $2.8M |
| 4 | Roche Holding AG ROCHE HOLDING AG-BR COMMON STOCK |
Stocks | 3.21% | $2.6M |
| 5 | Abbvie Inc. ABBVIE INC COMMON STOCK |
Stocks | 3.16% | $2.6M |
| 6 | Welltower Inc. WELLTOWER INC REIT |
Stocks | 3.07% | $2.5M |
| 7 | Ventas, Inc. VENTAS INC REIT |
Stocks | 3.06% | $2.5M |
| 8 | Merck & Co., Inc. MERCK & CO. INC. COMMON STOCK |
Stocks | 2.99% | $2.4M |
| 9 | Bristol-myers Squibb Company BRISTOL-MYERS SQUIBB CO COMMON STOCK |
Stocks | 2.98% | $2.4M |
| 10 | Amgen Inc. AMGEN INC COMMON STOCK |
Stocks | 2.93% | $2.4M |
| 11 | Johnson & Johnson JOHNSON & JOHNSON COMMON STOCK |
Stocks | 2.88% | $2.4M |
| 12 | Ucb Sa UCB SA COMMON STOCK |
Stocks | 2.86% | $2.3M |
| 13 | Astrazeneca Plc ASTRAZENECA PLC COMMON STOCK |
Stocks | 2.80% | $2.3M |
| 14 | Stryker Corporation STRYKER CORP COMMON STOCK |
Stocks | 2.78% | $2.3M |
| 15 | Chugai Pharmaceutical Co., Ltd. CHUGAI PHARMACEUTICAL CO LTD COMMON STOCK |
Stocks | 2.78% | $2.3M |
| 16 | Sandoz Group AG SANDOZ GROUP AG COMMON STOCK |
Stocks | 2.62% | $2.1M |
| 17 | Medtronic Public Limited Company MEDTRONIC PLC COMMON STOCK |
Stocks | 2.60% | $2.1M |
| 18 | Regeneron Pharmaceuticals, Inc. REGENERON PHARMACEUTICALS COMMON STOCK |
Stocks | 2.48% | $2.0M |
| 19 | Boston Scientific Corporation BOSTON SCIENTIFIC CORP COMMON STOCK |
Stocks | 2.44% | $2.0M |
| 20 | Alcon AG ALCON INC COMMON STOCK |
Stocks | 2.35% | $1.9M |
| 21 | BeOne Medicines AG BEONE MEDICINES LTD-ADR DEPOSITARY RECEIPT |
Stocks | 2.24% | $1.8M |
| 22 | Celltrion, Inc. CELLTRION INC COMMON STOCK |
Stocks | 2.10% | $1.7M |
| 23 | Dexcom, Inc. DEXCOM INC COMMON STOCK |
Stocks | 2.01% | $1.6M |
| 24 | Astellas Pharma Inc. ASTELLAS PHARMA INC COMMON STOCK |
Stocks | 1.83% | $1.5M |
| 25 | United Therapeutics Corporation UNITED THERAPEUTICS CORP COMMON STOCK |
Stocks | 1.73% | $1.4M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 29, 2026